top of page


We are committed to accelerating the use of personal cell and tissue therapies such as the use of mesenchymal stem cells (MSCs) and regenerative medicine.

"...the global stem cell therapy market will reach $180 billion by 2030."

"The Smart Money is Piling Into Regenerative Medicine."

"Mesenchymal Stem Cells Surpass Hematopoietic Stem Cells in the Scientific Literature"


Provia is a cGMP cell and tissue product and services company with specific expertise in the collection, transport, processing, manufacturing, testing, cryopreservation, storage and distribution of cells and tissues for autologous use.

Current Good Manufacturing Practices (cGMP)

"Facilities that are in good condition, equipment that is properly maintained and calibrated, employees who are qualified and fully trained, and processes that are reliable and reproducible, are a few examples of how cGMP requirements help to assure the safety and efficacy of drug products.” 
Source: FDA 

Autologous Use

"The implantation, transplantation, infusion, or transfer of human cells or tissue back into the individual from whom the tissue or cells are recovered."
Source: FDA

Dental stem cells are solid tissue forming stem cells
- raw materials for regenerative medicine.

Banking them gives our children better tools for a lifetime of healthy living.

The only dental stem cell banking option operating an FDA-registered cGMP cell manufacturing facility.


Contract Manufacturing & Cryopreservation Services

Cell therapy research, pre-clinical testing, process development, cell isolation, culture, manufacturing and cryopreservation services for proof of concept studies, protocol development, validation, and trials.

Small studies, small batch runs, personal service.


Proviasette biobanking containers are engineered to improve sample management.

Over 50 pharmaceutical, biotech and medical centers rely on Proviasettes for their biobanks.


Library of stem cell materials available for researchers.

Mesenchymal stem cells (MSCs) from dental pulp, adipose tissue, placental tissue, umbilical cord tissue, bone marrow, chorionic villi, and amniotic fluid.

Available for direct licensing or collaborative research agreements.


Bone marrow is a source material in over 300 active clinical trials.

Orthopedic surgeons, pain management and sports medicine clinics are commonly using a patient's own bone marrow for regenerative medicine applications.

Provia is seeking clinicians actively providing these services to join Provia's bone marrow banking network.

bottom of page